Praxis Precision Medicines, Inc. Common Stock Earnings Dividend
Earnings Summary
Net Profits | $-83.72Mn |
Praxis Precision Medicines, Inc. Common Stock’s net profit fell -17.7% since last year same period to $-83.72Mn in the Q2 2026. On a quarterly growth basis, Praxis Precision Medicines, Inc. Common Stock has generated 9.55% jump in its net profits since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -3.6 |
EPS Estimate Current Year | -3.6 |
Praxis Precision Medicines, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -3.6 - a 2.17% jump from last quarter’s estimates.
Praxis Precision Medicines, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -3.6.
Key Ratios
Earning Per Share (EPS) | -2.87 |
Praxis Precision Medicines, Inc. Common Stock’s earning per share (EPS) jumped 13.29% since last year same period to -2.87 in the Q2 2026. This indicates that the Praxis Precision Medicines, Inc. Common Stock has generated 13.29% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-08-06 | -3.6 | -2.87 | 20.28% |
2026-05-07 | -3.68 | -3.2 | 13.04% |
